Merck Gets Complete Response on Zetia, Atorvastatin Combo Drug
Merck has received a complete response letter asking for additional data on its cholesterol drug candidate that would combine Zetia with atorvastatin.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.